Clinical Trial: COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Early-Stage Breast Cancer
Study Type: OBSERVATIONAL
Official Title: COGNITION: Comprehensive Assessment of Clinical Features, Genomics and Further Molecular Markers to Identify Patients With Early Breast Cancer for Enrolment on Marker Driven Trials (Molecular Diagnost
Brief Summary:
The COGNITION diagnostic platform elucidates the biomarker profile of neoadjuvant chemotherapy-resistant residual bulk tumors in high risk early breast cancer patients.The major goal is to provide a framework for genomic profiling, which serves as infrastructure for systematic biomarker-screening and -stratification for concise therapy-arm allocation in the interventional clinical phase II trial COGNITION-GUIDE (NCT05332561).In patients, who display a poor response to standard-of-care neoadjuvant chemotherapy,…
Read more